Patient-assessed health in ankylosing spondylitis: A structured review

Rheumatology

Volumn 44, Issue 5, 2005, Pages 577-586

  Haywood, Kirstie L ^c   Garratt, A M ^a   Dawes, P T ^b  

^a UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^b Norwegian Health Services Research Centre   (Norway)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ankylosing spondylitis; Measuring properties; Patient assessed health

Indexed keywords

ACCURACY; ANKYLOSING SPONDYLITIS; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; FATIGUE; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; JOINT STIFFNESS; MEDICAL ASSESSMENT; MEDICAL INSTRUMENTATION; MEDICAL LITERATURE; PAIN; PATIENT MOBILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; REVIEW; SCORING SYSTEM; VALIDATION PROCESS; VISUAL ANALOG SCALE; HEALTH SURVEY; HOSPITALIZATION; PATIENT PARTICIPATION; PSYCHOMETRY; REPRODUCIBILITY;

HEALTH STATUS INDICATORS; HUMANS; PATIENT PARTICIPATION; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 21244464365     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keh549     Document Type: Review

References (98)

1. Russell AS. Ankylosing spondylitis - history. In: Klippel JH, Dieppe PA, eds. Rheumatology. 2nd edn. London: Mosby, 1998; 1:14.1-2.
2. Ward MM. Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 1998;24:815-27.
3. Garratt AM, Schmidt L, Macintosh A, Fitzpatrick R. Quality of life measurement: Bibliographic study of patient assessed health outcome measures. BMJ 2002;324:1417-21.
4. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998;2:1-74.
5. Calin A, Garrett S, Whitelock H et al. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis functional index. J Rheumatol 1994;21:2281-5.
6. Dougados M, Gueguen A, Nakache JP, Nguyen M, Merv C, Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988;15:302-7.
7. van der Heijde D, Bellamy N, Calin A, Dougadas M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol 1997;24:2225-9.
8. van der Heijde D, Calin A, Dougadas M, Khan MA, van der Linden S, Bellamy N. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol 1999;26:951-4.
9. Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use. 3rd edn. Oxford Medical Publications, 2003.
10. Garratt AM, Schmidt L, Fitzpatrick R. Patient-assessed health outcome measures for diabetes: A structured review. Diabet Med 2002;19:1-11.
11. McDowell I, Newell C. Measuring health. A guide to rating scales and questionnaires. 2nd edn. Oxford University Press, 1996.
12. Bowling A. Measuring disease. A review of disease-specific quality of life measurement scales. Buckingham: Open University Press, 1995.
13. Bowling A. Measuring health. A review of quality of life measurement scales. Buckingham: Open University Press, 1997.
14. Bakker C, Boers M, van der Linden S. Measures to assess ankylosing spondylitis: Taxonomy, review and recommendations. J Rheumatol 1993;20:1724-32.
15. Ruof J, Sagha O, Stucki G. Comparative responsiveness of three functional indices in ankylosing spondylitis. J Rheumatol 1999; 26:1959-63.
16. Ruof J, Stucki G. Comparison of the Dougados Functional Index and the Bath Ankylosing Spondylitis Functional Index. A literature review. J Rheumatol 1999;26:955-60.
17. Dagfinrud H, Hagen K. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Systematic Review 2001;CD002822.
18. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der Linden S, Brandt J. Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 2002;61(Suppl. 3):iIi40-50.
19. Braun J, Sieper J, Breban M et al. Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: International experience. Ann Rheum Dis 2002;61(Suppl. 3):iIi51-60.
20. Bellamy N. Clinimetric concepts in outcome assessment: The OMERACT filter. J Rheumatol 1999;26:948-50.
21. Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for responsiveness. J Clin Epidemiol 2001;54:1204-17.
22. Liang MH, Lew RA, Stucki G, Fortin PR, Daltroy L. Measuring clinically important changes with patient-oriented questionnaires. Med Care 2002;40(Suppl.):II45-51.
23. Norman GR, Sridhar FG, Guyatt GH, Walter SD. Relation of distribution and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 2001;39:1039-47.
24. Haywood KL, Hargreaves J, Lamb SE. Multi-item outcome measures for lateral ligament injury of the ankle: A structured review. J Eval Clin Pract 2004;10:339-52.
25. Haywood KL, Garratt AM, Fitzpatrick R. Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res 2004, in press.
26. Lee YS, Schlotzhauer T, Ott SM et al. Skeletal status of men with early and late ankylosing spondylitis. Am J Med 1997;103:233-41.
27. Santos H, Brophy S, Calin A. Exercise in ankylosing spondylitis: How much is optimum? J Rheumatol 1998;25:2156-60.
28. Garrett S, Jenkinson T, Kennedy G, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis disease activity index. J Rheumatol 1994;1:2286-91.
29. Dziedzic KSG. The Body Chart: A further sketch towards a fuller picture of ankylosing spondylitis. PhD thesis. University of Keele, UK, 1997.
30. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 1996;35:66-71.
31. Guillemin F, Challier B, Urlacher F, Vancon G, Pourel J. Quality of life in ankylosing spondylitis: Validation of the ankylosing spondylitis Arthritis Impact Measurement Scales 2, a modified Arthritis Impact Measurement Scales Questionnaire. Arthritis Care Res 1999;2:157-62.
32. Fries JF. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
33. Daltroy LH, Larson MG, Roberts WN, Liang MH. A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 1990;17:946-50.
34. Bakker C, Hidding A, van der Linden S, van Doorslaer E. Cost effectiveness of group physical therapy compared to individualised therapy for ankylosing spondylitis. A randomised controlled trial. J Rheumatol 1994;21:264-8.
35. Bell MJ, Bombardier C, Tugwell P. Measurement of functional status, quality of life, and utility in rheumatoid arthritis. Arthritis Rheum 1990;33:591-601.
36. Haywood KL, Garratt AM, Dziedzic K, Dawes PT. Patient centered assessment of ankylosing spondylitis-specific health related quality of life: Evaluation of the Patient Generated Index. J Rheumatol 2003;30:764-73.
37. Nemeth R, Smith F, Elswood J, Calin A. Ankylosing spondylitis (AS) - an approach to measurement of severity and outcome: Ankylosing Spondylitis Assessment Questionnaire (ASAQ) - a controlled study. Br J Rheumatol 1987;Suppl. 1:69-70.
38. Abbott CA, Helliwell, PS, Chamberlain MA. Functional assessment in ankylosing spondylitis - Evaluation of a new self-administered questionnaire and correlation with anthropometric variables. Br J Rheumatol 1994;33:1060-6.
39. Doward LC, Spoorenberg A, Cook SA et al. Development of the ASQoL: A quality of life instruments specific to ankylosing spondylitis. Ann Rheum Dis 2003;62:20-6.
40. Meenan RF, Gertmen PM, Mason JH. Measuring health status in arthritis. The Arthritis Impact Measurement Scales. Arthritis Rheum 1980;23:146-52.
41. Meenan RF, Mason JH, Anderson JJ. AIMS2: The contents and properties of a revised and expanded Arthritis Impacts Measurement Scales health status questionnaire. Arthritis Rheum 1992;35:1-10.
42. Jones SD, Calin A, Steiner A. An update on the Bath Ankylosing Spondylitis Disease Activity and functional indices (BASDAI, BASFI): excellent Cronbach's alpha scores [letter]. J Rheumatol 1996;23:407.
43. Haywood KL, Garratt AM, Jordan K, Dziedzic K, Dawes PT. Disease-specific patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology 2002;41:1295-302.
44. Bostan EE, Borman P, Bodur H, Barca N. Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 2003;23:121-6.
45. Creemers MCW, van't Hof MA, Fransse MJAM, van de Putte LBA, Gribnau FWJ, van Riel PLCM. A Dutch version of the Functional Index for Ankylosing Spondylitis: Development and validation in a long term study. Br J Rheumatol 1994;33:841-6.
46. Heikkila S, Viitanen JV, Kautianen H et al. Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondylarthropathy. Clin Rheumatol 2000;19:464-9.
47. Claudepierre P, Sibilia J, Goupille P et al. Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol 1997; 24:1954-8.
48. Claudepierre P, Sibilia J, Roudot-Thoraval F et al. Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. J Rheumatol 1998;25:1927-31.
49. Calin A, Nakache JP, Guegen A, Zeidler H, Mielants H, Dougadas M. Defining disease activity in ankylosing spondylitis: Is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatolopy 1999;38:878-82.
50. Falkenbach A, Franke A, van Tubergen A, van der Linden S. Assessment of functional ability in younger and older patients with ankylosing spondylitis: Performance of the Bath Ankylosing Spondylitis Functional Index. Am J Phys Med Rehabil 2002; 81:416-20.
51. Auleley GR, Benbouazza K, Spoorenberg A et al. Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis. Arthritis Rheum 2002;47:582-7.
52. Eyres S, Tennant A, Kay L, Waxman R, Helliwell P. Measuring disability in ankylosing spondylitis: Comparison of Bath AS Functional Index with Revised Leeds Disability Questionnaire. J Rheumatol 2002;29:979-86.
53. Anderson JJ, Baron G, van der Heijde D. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001;44:1876-86.
54. Van Tubergen A, Debats I, Ryser L et al. Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. Arthritis Rheum 2002;47:242-8.
55. Hidding A, van der Linden SJ, Boers M et al. Is group physical therapy superior to individualised therapy in ankylosing spondylitis? Arthritis Care Res 1993;6:117-25.
56. Hidding A, van der Linden SJ, Gielen X, de Witte L, Dijkmans B, Moolenburgh M. Continuation of group physical therapy is necessary in ankylosing spondylitis: Results of a randomised controlled trial. Arthritis Care Res 1994;7:90-6.
57. Bakker C, Rutten-van-Molken M, Hidding A, van Doorslaer E, Bennett K, van der Linden S. Patient utilities in ankylosing spondylitis and the association with other outcome measures. J Rheumatol 1994;21:1298-304.
58. Bakker C, van der Linden SJ, van Santen-Hoeufft M, Bolwijn P, Hidding A. Problem elicitation to assess patient priorities in ankylosing spondylitis and fibromyalgia. J Rheumatol 1995;22:1304-10.
59. Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Outcome variables in ankylosing spondylitis: Evaluation of their relevance and discriminant capacity. J Rheumatol 1999;26: 975-9.
60. Braun J, Brandt J, Listing J et al. Treatment of active ankylosing spondylitis with infliximab: A randomised controlled multicentre trial. Lancet 2002;359:1187-93.
61. Temekonidis TI, Alamanos Y, Nikas SN. Infliximab therapy in patients with ankylosing spondylitis: An open label 12 month study. Ann Rheum Dis 2003;62:1218-20.
62. Braun J, Brandt J, Listing J et al. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis. An open, observational, extension study of a three-month, randomised, placebo-controlled trial. Arthritis Rheum 2003;48:2224-33.
63. Brandt J, Khariouzou A, Listing J et al. Six-month results of a double-blind, placebo-controlled trial of Etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 2003;48:1667-75.
64. Dougados M, Behier JM, Jolchine I et al. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis. Arthritis Rheum 2001;44:180-5.
65. Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002;346:1349-56.
66. Wanders AJB, Gorman JD, Davis JC, Landewe RBM, van der Heijde DMFM. Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of Etanercept in ankylosing spondylitis. Arthritis Rheum 2004;51:1-8.
67. Heikkila S, Viitanen JV, Kautiainen H, Kauppi M. Does improved spinal mobility correlate with functional changes in spondyloarthropathy after short term physical therapy? J Rheumatol 2000;27:2942-4.
68. van Tubergen A, Landewe R, Heuft-Dorenbosch L et al. Assessment of disability with the World Health Organization Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:140-5.
69. Van Tubergen A, Landewe R, van der Heijde D et al. Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: A randomized controlled trial. Arthritis Rheum 200;45:430-8.
70. Band DA, Jones SD, Kennedy LG et al. Which patients with ankylosing spondylitis derive most benefit from an in-patient management program? J Rheumatol 1997;24:2381-4.
71. Waldner A, Cronstedt H, Stenstrom CH. The Swedish version of the Bath Ankylosing Spondylitis Disease Activity Index. Reliability and validity. Scand J Rheumatol Suppl 1999;111:10-6.
72. Viitanen JV, Heikkila S. Functional changes in patients with spondylarthropathy. A controlled trial of the effects of short-term rehabilitation and 3-year follow-up. Rheumatol Int 2001;20:211-4.
73. Sweeney S, Taylor G, Calin A. The effect of a home based exercise intervention package on outcome in ankylosing spondylitis: A randomized controlled trial. J Rheumatol 2002;29:763-6.
74. Heikkila S. The Dougados functional index with the 5-point Likert scale is sensitive to change due to intensive physiotherapy and exercise in spondyloarthropathy. Clin Exp Rheumatol 2002; 20:689-92.
75. Heikkila S, Viitanen JV, Kautiainen H, Kauppi M. Functional long-term changes in patients with spondylarthropathy. Clin Rheumatol 2002;21:119-22.
76. Cronstedt H, Waldner A, Stenstrom CH. The Swedish version of the Bath Ankylosing Spondylitis Functional Index. Reliability and validity. Scand J Rheumatol Suppl 1999;111:1-9.
77. Van Tubergen A, Boonen A, Landewe R et al. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: A randomized controlled trial. Arthritis Rheum 2002;47:459-67.
78. Analay Y, Ozcan E, Karan A, Diracoglu D, Aydin R. The effectiveness of intensive group exercise on patients with ankylosing spondylitis. Clin Rehabil 2003;17:631-6.
79. Stone M, Salonen D, Lax M, Payne U, Lapp V, Inman R. Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis. J Rheumatol 2001;28:1605-14.
80. Ward MM, Kuzis S. Validity and sensitivity to change of spondylitis-specific measures of functional disability. J Rheumatol 1999;26:121-7.
81. Maksymowych WP, Jhangri GS, Leclercq S, Skeith K, Yan A, Russell AS. An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol 1998;25:714-7.
82. Maksymowych WP, Jbangri GS. Lambert RG et al. Infliximab in ankylosing spondylitis: A prospective observational inception cohort analysis of efficacy and safety. J Rheumatol 2002;29:959-65.
83. Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: A clinical and magnetic resonance imaging study. Arthritis Rheum 200;44:2112-7.
84. Helliwell PS, Marzo-Ortega H, Tennant A. Comparison of a disease-specific and a generic instrument for measuring health-related quality of life in ankylosing spondylitis. Arthritis Rheum 2002; 46:3098.
85. Spoorenberg A, van der Heijde D, de Klerk E et al. A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. J Rheumatol 1999;26:961-5.
86. Saag KG. OMERACT 6 brings new perspectives to rheumatology measurement research. J Rheumatol 2003;30:639-41.
87. Dziedzic K. Ankylosing spondylitis. In: David C, Lloyd J, eds. Rheumatological physiotherapy. London: Mosby, 1998:97-114.
88. Bellamy N, Kaloni S, Pope J, Coulter K, Campbell J. Quantitative rheumatology: A survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. J Rheumatol 1998;25:852-8.
89. Bellamy N, Muirden KD, Brooks PM. Barraclough D, Tellus MM, Campbell J. A survey of outcome measurement procedures in routine rheumatology outpatient practice in Australia. J Rheumatol 1999;26:1593-9.
90. McHorney CA, Cohen AS. Equating health status measures with item response theory: Illustrations with functional status measures. Med Care 2000;38(Suppl. II):II-43-II-59.
91. Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PMM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003;12:349-62.
92. van Tubergen A, Coenen J, Landewe R et al. Assessment of fatigue in patients with ankylosing spondylitis: A psychometric analysis. Arthritis Care Res 2002;47:8-16.
93. Greenhalgh J, Meadows K. The effectiveness of the use of patient-based measures of health in routine practice in improving the process and outcomes of patient care: A literature review. J Clin Eval Clin Pract 1999;5:401-16.
94. Stone MA, Inman RD, Wright JG, Maetzel A. Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) Group response criteria in ankylosing spondylitis patients treated with biologics. Arthritis Rheum 2004;51:316-20.
95. Garratt AM in collaboration with the UK Back Pain Exercise and Manipulation Trial. Rasch analysis of the Roland Disability Questionnaire. Spine 2003;28:79-84.
96. Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH. Interpretation of change scores in ordinal clinical scale and health status measures: The whole may not equal the sum of the parts. J Clin Epidemiol 1996;49:711-7.
97. Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003;56:52-60.
98. Ware JE. SF-36 Health Survey manual and interpretation guide. Boston: Medical Outcomes Trust, 1997.